Literature DB >> 11080221

Neurological rehabilitation: from mechanisms to management.

A J Thompson1.   

Abstract

Mesh：

Year:  2000        PMID： 11080221      PMCID： PMC1737188          DOI： 10.1136/jnnp.69.6.718

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  44 in total

1.  Brain atrophy as a surrogate marker in MS: faster, simpler, better?

Authors:  W J Jagust; J H Noseworthy
Journal:  Neurology       Date:  2000-02-22       Impact factor: 9.910

2.  Axonal lesions in multiple sclerosis: an old story revisited.

Authors:  T Revesz
Journal:  Brain       Date:  2000-02       Impact factor: 13.501

3.  Rehabilitation still the only way to improve function in multiple sclerosis.

Authors:  G H Kraft
Journal:  Lancet       Date:  1999-12-11       Impact factor: 79.321

4.  Measuring handicap: the London Handicap Scale, a new outcome measure for chronic disease.

Authors:  R H Harwood; A Rogers; E Dickinson; S Ebrahim
Journal:  Qual Health Care       Date:  1994-03

5.  The motor cortex shows adaptive functional changes to brain injury from multiple sclerosis.

Authors:  M Lee; H Reddy; H Johansen-Berg; S Pendlebury; M Jenkinson; S Smith; J Palace; P M Matthews
Journal:  Ann Neurol       Date:  2000-05       Impact factor: 10.422

6.  MRI dynamics of brain and spinal cord in progressive multiple sclerosis.

Authors:  D Kidd; J W Thorpe; B E Kendall; G J Barker; D H Miller; W I McDonald; A J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-01       Impact factor: 10.154

7.  Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss.

Authors:  C A Davie; G J Barker; S Webb; P S Tofts; A J Thompson; A E Harding; W I McDonald; D H Miller
Journal:  Brain       Date:  1995-12       Impact factor: 13.501

8.  Progressive cerebral atrophy in MS: a serial study using registered, volumetric MRI.

Authors:  N C Fox; R Jenkins; S M Leary; V L Stevenson; N A Losseff; W R Crum; R J Harvey; M N Rossor; D H Miller; A J Thompson
Journal:  Neurology       Date:  2000-02-22       Impact factor: 9.910

9.  Kurtzke scales revisited: the application of psychometric methods to clinical intuition.

Authors:  J Hobart; J Freeman; A Thompson
Journal:  Brain       Date:  2000-05       Impact factor: 13.501

10.  Recovery from optic neuritis is associated with a change in the distribution of cerebral response to visual stimulation: a functional magnetic resonance imaging study.

Authors:  D J Werring; E T Bullmore; A T Toosy; D H Miller; G J Barker; D G MacManus; M J Brammer; V P Giampietro; A Brusa; P A Brex; I F Moseley; G T Plant; W I McDonald; A J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-04       Impact factor: 10.154
View more
  4 in total

1.  Symptomatic management and rehabilitation in multiple sclerosis.

Authors:  A J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-12       Impact factor: 10.154

Review 2.  Clinical implications of neuroplasticity - the role of rehabilitation in multiple sclerosis.

Authors:  Peter Flachenecker
Journal:  Front Neurol       Date:  2015-03-03       Impact factor: 4.003

Review 3.  A Review of Robotics in Neurorehabilitation: Towards an Automated Process for Upper Limb.

Authors:  E D Oña; R Cano-de la Cuerda; P Sánchez-Herrera; C Balaguer; A Jardón
Journal:  J Healthc Eng       Date:  2018-04-01       Impact factor: 2.682

4.  Content and Delivery of Physical Therapy in Multiple Sclerosis across Europe: A Survey.

Authors:  Kamila Řasová; Jenny Freeman; Davide Cattaneo; Johanna Jonsdottir; Ilse Baert; Tori Smedal; Anders Romberg; Peter Feys; Jose Alves-Guerreiro; Mario Habek; Thomas Henze; Carme Santoyo-Medina; Antonie Beiske; Paul Van Asch; Daphne Bakalidou; Yeliz Salcı; Erieta Dimitrova; Markéta Pavlíková; Ivana Štětkářová; Jana Vorlíčková; Patricia Martinková
Journal:  Int J Environ Res Public Health       Date:  2020-01-31       Impact factor: 3.390
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.